Global Endometrial Cancer Therapeutics Market 2018-2022 | Emergence of Immune Therapy to Boost Demand | Technavio

LONDON–(BUSINESS WIRE)–#NovartisTechnavio
analysts forecast the global endometrial cancer therapeutics market to
grow at a CAGR of over 5% during the forecast period, according
to their latest market research report.

The emergence of immune therapy is one of the major trends being
witnessed in the global
endometrial cancer therapeutics market 2018-2022
. Immune therapy
also known as biological therapy is a type of cancer treatment that
improves the defense mechanism of the body to fight against cancer. It
uses substances synthesized by the body or in a laboratory to restore
immune system function. Immunotherapy works by hindering or slowing the
growth of the cancer cells. Also, it stops from spreading to other parts
of the body.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

According to Technavio analysts, one of the key factors contributing to
the growth of the global endometrial cancer therapeutics market is the
increasing prevalence of endometrial cancer:

Global endometrial cancer therapeutics market:
Increasing prevalence of endometrial cancer

Endometrial cancer is one of the most common gynecological malignancies,
the incidence of which is increasing globally. The prevalence rate of
endometrial cancer
has been rising due to the changing lifestyle. As more than 80% of
the endometrial cancers are estrogen related, changing lifestyle and
socioeconomic factors that affect the estrogen exposure are related to a
recent increase in prevalence rate.

According to a senior analyst at Technavio for research on oncology,
“Endometrial cancer is most common in Western countries and is more
prevalent in postmenopausal women. As per an article published in the
NCB, in 2015, in Romania, endometrial cancer recorded a peak incidence
in the age group of 60-64 years, which reached an average value of 8.06
cases per 100,000 women in 2013. Also, 35% of the endometrial cases were
diagnosed in their advanced stage, with significantly diminished life

Global endometrial cancer therapeutics market:
Segmentation analysis

The global endometrial cancer therapeutics market research report
provides market segmentation by product (chemotherapy and hormone
therapy) and by region (the Americas, EMEA, and APAC). It provides an
in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific

Of the two major products, the chemotherapy segment held the largest
market share in 2017, contributing to close to 74% of the market. This
product segment will dominate the global market throughout the forecast

The Americas held the largest share of the market in 2017, accounting
for more than 44% share. It was followed by EMEA and APAC respectively.
The region is expected to continue to dominate the market.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.


Technavio Research
Jesse Maida
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200


I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.